HomeCompareIVIXF vs PM

IVIXF vs PM: Dividend Comparison 2026

IVIXF yields 5420.05% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVIXF wins by $136326195118802.19M in total portfolio value
10 years
IVIXF
IVIXF
● Live price
5420.05%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$136326195118802.23M
Annual income
$131,551,666,493,773,860,000.00
Full IVIXF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — IVIXF vs PM

📍 IVIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVIXFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVIXF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IVIXF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVIXF
Annual income on $10K today (after 15% tax)
$460,704.61/yr
After 10yr DRIP, annual income (after tax)
$111,818,916,519,707,770,000.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, IVIXF beats the other by $111,818,916,519,707,770,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVIXF + PM for your $10,000?

IVIXF: 50%PM: 50%
100% PM50/50100% IVIXF
Portfolio after 10yr
$68163097559401.14M
Annual income
$65,775,833,246,886,930,000.00/yr
Blended yield
96.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

IVIXF
No analyst data
Altman Z
-30.2
Piotroski
1/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVIXF buys
0
PM buys
0
No recent congressional trades found for IVIXF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVIXFPM
Forward yield5420.05%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$136326195118802.23M$49.6K
Annual income after 10y$131,551,666,493,773,860,000.00$2,492.02
Total dividends collected$136003983287005.17M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IVIXF vs PM ($10,000, DRIP)

YearIVIXF PortfolioIVIXF Income/yrPM PortfolioPM Income/yrGap
1← crossover$552,705$542,005.42$11,648$408.29+$541.1KIVIXF
2$28,588,529$27,997,133.96$13,589$495.90+$28.57MIVIXF
3$1,383,995,048$1,353,405,322.61$15,877$603.21+$1383.98MIVIXF
4$62,714,057,337$61,233,182,635.19$18,580$734.88+$62714.04MIVIXF
5$2,660,288,543,813$2,593,184,502,462.66$21,781$896.75+$2660288.52MIVIXF
6$105,651,330,702,723$102,804,821,960,842.73$25,578$1,096.12+$105651330.68MIVIXF
7$3,928,761,972,612,137$3,815,715,048,760,222.50$30,092$1,342.17+$3928761972.58MIVIXF
8$136,812,745,737,264,320$132,608,970,426,569,340.00$35,470$1,646.46+$136812745737.23MIVIXF
9$4,462,176,285,073,260,500$4,315,786,647,134,387,700.00$41,892$2,023.58+$4462176285073.22MIVIXF
10$136,326,195,118,802,240,000$131,551,666,493,773,860,000.00$49,578$2,492.02+$136326195118802.19MIVIXF

IVIXF vs PM: Complete Analysis 2026

IVIXFStock

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full IVIXF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this IVIXF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVIXF vs SCHDIVIXF vs JEPIIVIXF vs OIVIXF vs KOIVIXF vs MAINIVIXF vs MOIVIXF vs BTIIVIXF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.